BioXcel Therapeutics Inc (BTAI)
2.57
+0.01
(+0.39%)
USD |
NASDAQ |
May 03, 16:00
2.57
0.00 (0.00%)
Pre-Market: 20:00
BioXcel Therapeutics Accounts Payable (Quarterly): 13.65M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.65M |
| September 30, 2023 | 10.67M |
| June 30, 2023 | 11.20M |
| March 31, 2023 | 7.742M |
| December 31, 2022 | 10.23M |
| September 30, 2022 | 5.872M |
| June 30, 2022 | 6.021M |
| March 31, 2022 | 5.065M |
| December 31, 2021 | 4.678M |
| September 30, 2021 | 3.439M |
| June 30, 2021 | 2.497M |
| March 31, 2021 | 5.31M |
| December 31, 2020 | 3.979M |
| Date | Value |
|---|---|
| September 30, 2020 | 8.557M |
| June 30, 2020 | 10.43M |
| March 31, 2020 | 6.733M |
| December 31, 2019 | 4.953M |
| September 30, 2019 | 4.238M |
| June 30, 2019 | 3.979M |
| March 31, 2019 | 2.128M |
| December 31, 2018 | 1.604M |
| September 30, 2018 | 1.213M |
| June 30, 2018 | 0.889M |
| March 31, 2018 | 3.935M |
| December 31, 2017 | 0.444M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.497M
Minimum
Jun 2021
13.65M
Maximum
Dec 2023
6.803M
Average
5.872M
Median
Sep 2022
Accounts Payable (Quarterly) Benchmarks
| Synlogic Inc | 1.457M |
| Cormedix Inc | 4.280M |
| Bristol-Myers Squibb Co | 3.539B |
| Verastem Inc | 7.184M |
| Ocular Therapeutix Inc | 4.389M |